BCTX Annual Cash & Cash Equivalents
$862.10 K
-$20.39 M-95.94%
31 July 2024
Summary:
As of January 23, 2025, BCTX annual cash & cash equivalents is $862.10 thousand, with the most recent change of -$20.39 million (-95.94%) on July 31, 2024. During the last 3 years, it has fallen by -$56.41 million (-98.49%). BCTX annual cash & cash equivalents is now -98.49% below its all-time high of $57.27 million, reached on July 31, 2021.BCTX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCTX Quarterly Cash And Cash Equivalents
$5.79 M
+$4.93 M+571.88%
31 October 2024
Summary:
As of January 23, 2025, BCTX quarterly cash and cash equivalents is $5.79 million, with the most recent change of +$4.93 million (+571.88%) on October 31, 2024. Over the past year, it has dropped by -$7.85 million (-57.55%). BCTX quarterly cash and cash equivalents is now -89.89% below its all-time high of $57.27 million, reached on July 31, 2021.BCTX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCTX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -95.9% | -57.5% |
| 3 y3 years | -98.5% | -57.5% |
| 5 y5 years | +449.1% | -57.5% |
BCTX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.5% | at low | -89.6% | +571.9% |
| 5 y | 5-year | -98.5% | +3966.5% | -89.9% | >+9999.0% |
| alltime | all time | -98.5% | +3966.5% | -89.9% | >+9999.0% |
BriaCell Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $5.79 M(+571.9%) |
| July 2024 | $862.10 K(-95.9%) | $862.10 K(-7.9%) |
| Apr 2024 | - | $935.70 K(-85.0%) |
| Jan 2024 | - | $6.24 M(-54.2%) |
| Oct 2023 | - | $13.65 M(-35.8%) |
| July 2023 | $21.25 M(-48.2%) | $21.25 M(-24.6%) |
| Apr 2023 | - | $28.17 M(-15.9%) |
| Jan 2023 | - | $33.50 M(-10.6%) |
| Oct 2022 | - | $37.45 M(-8.7%) |
| July 2022 | $41.04 M(-28.3%) | $41.04 M(-7.8%) |
| Apr 2022 | - | $44.53 M(-7.2%) |
| Jan 2022 | - | $47.98 M(-13.5%) |
| Oct 2021 | - | $55.49 M(-3.1%) |
| July 2021 | $57.27 M(>+9900.0%) | $57.27 M(+185.2%) |
| Apr 2021 | - | $20.08 M(>+9900.0%) |
| Jan 2021 | - | $5700.00(-10.9%) |
| Oct 2020 | - | $6400.00(-69.8%) |
| July 2020 | $21.20 K(-86.5%) | $21.20 K(-60.4%) |
| Apr 2020 | - | $53.50 K(-24.5%) |
| Jan 2020 | - | $70.90 K(+21.0%) |
| Oct 2019 | - | $58.60 K(-62.7%) |
| July 2019 | $157.00 K(-78.2%) | $157.00 K(-77.5%) |
| Apr 2019 | - | $697.80 K(+83.7%) |
| Jan 2019 | - | $379.90 K(+25.8%) |
| Oct 2018 | - | $302.00 K(-58.1%) |
| July 2018 | $720.30 K(-29.0%) | $720.30 K(+169.4%) |
| Apr 2018 | - | $267.40 K(+35.0%) |
| Jan 2018 | - | $198.10 K(-60.6%) |
| Oct 2017 | - | $502.20 K(-50.5%) |
| July 2017 | $1.01 M(+670.9%) | $1.01 M(+15.6%) |
| Apr 2017 | - | $877.70 K(+150.1%) |
| Jan 2017 | - | $351.00 K(+258.2%) |
| Oct 2016 | - | $98.00 K(-25.5%) |
| July 2016 | $131.60 K(-63.2%) | $131.60 K(-88.9%) |
| Apr 2016 | - | $1.18 M(+110.0%) |
| Jan 2016 | - | $563.70 K(+963.6%) |
| Oct 2015 | - | $53.00 K(-85.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| July 2015 | $357.20 K(+1394.6%) | $357.20 K(+40.7%) |
| Apr 2015 | - | $253.90 K(-19.1%) |
| Jan 2015 | - | $314.00 K(-52.1%) |
| Oct 2014 | - | $656.10 K(+2645.2%) |
| July 2014 | $23.90 K(-97.5%) | $23.90 K(-97.2%) |
| Apr 2014 | - | $845.60 K(-0.3%) |
| Jan 2014 | - | $847.80 K(-11.7%) |
| Oct 2013 | - | $959.70 K(-0.7%) |
| July 2013 | $966.50 K(-35.7%) | $966.50 K(-9.6%) |
| Apr 2013 | - | $1.07 M(-7.3%) |
| Jan 2013 | - | $1.15 M(-28.8%) |
| Oct 2012 | - | $1.62 M(+7.7%) |
| July 2012 | $1.50 M(-62.0%) | $1.50 M(-33.3%) |
| Apr 2012 | - | $2.25 M(-7.1%) |
| Jan 2012 | - | $2.42 M(-12.2%) |
| Oct 2011 | - | $2.76 M(-30.1%) |
| July 2011 | $3.95 M(+188.9%) | $3.95 M(-43.5%) |
| Apr 2011 | - | $6.99 M(+531.1%) |
| Jan 2011 | - | $1.11 M(-13.8%) |
| Oct 2010 | - | $1.29 M(-5.9%) |
| July 2010 | $1.37 M(+79.4%) | $1.37 M(-11.7%) |
| Apr 2010 | - | $1.55 M(+170.5%) |
| Jan 2010 | - | $572.40 K(-7.1%) |
| Oct 2009 | - | $615.90 K(-19.1%) |
| July 2009 | $761.70 K(+117.3%) | $761.70 K(+116.2%) |
| Apr 2009 | - | $352.30 K(+86.2%) |
| Jan 2009 | - | $189.20 K(-13.4%) |
| Oct 2008 | - | $218.50 K(-37.7%) |
| July 2008 | $350.60 K(-21.3%) | $350.60 K(-18.1%) |
| Apr 2008 | - | $428.30 K(-6.0%) |
| Jan 2008 | - | $455.80 K(-7.4%) |
| Oct 2007 | - | $492.30 K(+10.5%) |
| July 2007 | $445.40 K(+403.8%) | $445.40 K(-1.2%) |
| Apr 2007 | - | $450.90 K(+3.8%) |
| Jan 2007 | - | $434.40 K(-9.7%) |
| Oct 2006 | - | $480.80 K |
| July 2006 | $88.40 K | - |
FAQ
- What is BriaCell Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual cash & cash equivalents year-on-year change?
- What is BriaCell Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly cash and cash equivalents year-on-year change?
What is BriaCell Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of BCTX is $862.10 K
What is the all time high annual cash & cash equivalents for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual cash & cash equivalents is $57.27 M
What is BriaCell Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, BCTX annual cash & cash equivalents has changed by -$20.39 M (-95.94%)
What is BriaCell Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BCTX is $5.79 M
What is the all time high quarterly cash and cash equivalents for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly cash and cash equivalents is $57.27 M
What is BriaCell Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, BCTX quarterly cash and cash equivalents has changed by -$7.85 M (-57.55%)